KLRS
Kalaris Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 2:49:01 PM EST
1.34USD-2.190%(-0.03)19,847
KLRS Financials
In Q3 FY 2026 (ended ), Kalaris Therapeutics, Inc. Common Stock (KLRS) reported net income of −$11.03M, operating cash flow of −$10.56M, and assets of $89M (filed ).
Loading financial statements…